- Home
- LPTX vs CBFV Comparison
LPTX vs CBFV Comparison
Compare LPTX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- CBFV
- Stock Information
- Founded
- LPTX 2011
- CBFV 1901
- Country
- LPTX United States
- CBFV United States
- Employees
- LPTX N/A
- CBFV N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- CBFV Major Banks
- Sector
- LPTX Health Care
- CBFV Finance
- Exchange
- LPTX Nasdaq
- CBFV Nasdaq
- Market Cap
- LPTX 119.6M
- CBFV 140.0M
- IPO Year
- LPTX N/A
- CBFV N/A
- Fundamental
- Price
- LPTX $0.33
- CBFV $28.65
- Analyst Decision
- LPTX Hold
- CBFV Hold
- Analyst Count
- LPTX 1
- CBFV 2
- Target Price
- LPTX N/A
- CBFV $26.00
- AVG Volume (30 Days)
- LPTX 3.3M
- CBFV 43.0K
- Earning Date
- LPTX 08-11-2025
- CBFV 07-23-2025
- Dividend Yield
- LPTX N/A
- CBFV 3.44%
- EPS Growth
- LPTX N/A
- CBFV N/A
- EPS
- LPTX N/A
- CBFV 1.92
- Revenue
- LPTX N/A
- CBFV $49,545,000.00
- Revenue This Year
- LPTX N/A
- CBFV $5.97
- Revenue Next Year
- LPTX N/A
- CBFV $9.49
- P/E Ratio
- LPTX N/A
- CBFV $15.15
- Revenue Growth
- LPTX N/A
- CBFV N/A
- 52 Week Low
- LPTX $0.22
- CBFV $22.16
- 52 Week High
- LPTX $4.79
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- LPTX 48.69
- CBFV 57.50
- Support Level
- LPTX $0.28
- CBFV $28.78
- Resistance Level
- LPTX $0.36
- CBFV $29.43
- Average True Range (ATR)
- LPTX 0.04
- CBFV 0.50
- MACD
- LPTX 0.01
- CBFV 0.17
- Stochastic Oscillator
- LPTX 39.43
- CBFV 83.19
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.